Form 4: Mineralys Therapeutics Officer Exercises Stock Options
SEC Form 4 Filing
David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics, exercised stock options at prices of $0.54 and $1.08, acquiring 5,017 and 6,349 shares respectively.
Summary
- David Malcom Rodman, the Chief Medical Officer of Mineralys Therapeutics, exercised stock options on June 11, 2024, and June 12, 2024.
- On June 11, 2024, Rodman exercised options to acquire 5,017 shares of common stock at a price of $0.54 per share.
- On June 12, 2024, Rodman exercised options to acquire 6,349 shares of common stock at a price of $1.08 per share.
- Following these transactions, Rodman directly owns 89,729 shares of Mineralys Therapeutics.
- Rodman also holds options for 190,357 shares after the reported transactions.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option exercises. The officer's actions could be interpreted as a positive signal, but it's not definitively bullish.
Positives
- The exercise of stock options by a company officer can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| March 12, 2022 | 25% of the stock option with exercise price $0.54 vested. |
| February 9, 2023 | Date of Reporting Person's Form 3 filing. |
| July 12, 2023 | 25% of the stock option with exercise price $1.08 vested. |
| June 11, 2024 | Rodman exercised options to acquire 5,017 shares at $0.54. |
| June 12, 2024 | Rodman exercised options to acquire 6,349 shares at $1.08. |
| June 13, 2024 | Date of signature on the Form 4 filing. |
| March 11, 2031 | Expiration date of stock option with exercise price $0.54. |
| July 11, 2032 | Expiration date of stock option with exercise price $1.08. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.